Biologic Excipient Industry to Reach USD 2,241.8 Million by 2034 at a 4.10% of CAGR, Bolstered by Growing Biopharmaceutical Pipeline and Demand for Specialized Therapies
The global biologic excipient market is projected to grow from USD 1.5 billion in 2024